We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$92.6M
AUM Growth
+$5.75M
Cap. Flow
+$2.55M
Cap. Flow %
2.76%
Top 10 Hldgs %
32.24%
Holding
102
New
26
Increased
26
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.58M
2
VTRS icon
Viatris
VTRS
+$3.19M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.28M
4
ELV icon
Elevance Health
ELV
+$1.89M
5
MSFT icon
Microsoft
MSFT
+$1.76M

Top Sells

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$4.96M
2
NOW icon
ServiceNow
NOW
+$1.78M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.34M
4
CI icon
Cigna
CI
+$1.28M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 64.08%
2 Technology 15.15%
3 Miscellaneous 7.32%
4 Communication Services 6.25%
5 Financials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNA
1
DELISTED
Allena Pharmaceuticals
ALNA
$5.7M 6.15%
575,407
– –
BMY icon
2
Bristol-Myers Squibb
BMY
$136B
$3.52M 3.81%
+55,719
New +$3.58M
VTRS icon
3
Viatris
VTRS
$18.8B
$3.08M 3.33%
+74,850
New +$3.19M
ELV icon
4
Elevance Health
ELV
$85.5B
$3.02M 3.26%
13,753
+8,064
+142% +$1.89M
BAX icon
5
Baxter International
BAX
$13.5B
$2.81M 3.03%
43,151
+16,104
+60% +$1.09M
MSFT icon
6
Microsoft
MSFT
$3.81T
$2.51M 2.71%
27,467
+19,198
+232% +$1.76M
PTLA
7
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.36M 2.55%
72,284
-12,833
-15% -$563K
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.35M 2.53%
+15,538
New +$2.28M
UNH icon
9
UnitedHealth
UNH
$353B
$2.28M 2.47%
10,667
+2,759
+35% +$630K
ABT icon
10
Abbott
ABT
$195B
$2.21M 2.39%
36,915
+149
+0.4% +$8.98K
GDDY icon
11
GoDaddy
GDDY
$12.4B
$2.07M 2.23%
33,638
-16,781
-33% -$949K
ZBH icon
12
Zimmer Biomet
ZBH
$19.2B
$2.03M 2.19%
19,158
+4,391
+30% +$510K
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
$1.98M 2.14%
36,471
+2,783
+8% +$156K
PBYI icon
14
Puma Biotechnology
PBYI
$468M
$1.85M 2%
27,154
+785
+3% +$58.8K
HUM icon
15
Humana
HUM
$46.3B
$1.81M 1.96%
6,738
+486
+8% +$132K
PYPL icon
16
PayPal
PYPL
$45.9B
$1.76M 1.9%
23,143
+5,124
+28% +$406K
MOH icon
17
Molina Healthcare
MOH
$10.4B
$1.74M 1.88%
21,387
+1,282
+6% +$103K
DATA
18
DELISTED
Tableau Software, Inc.
DATA
$1.69M 1.82%
+20,886
New +$1.65M
CRM icon
19
Salesforce
CRM
$211B
$1.67M 1.81%
14,383
-6,956
-33% -$799K
BMY icon
20
CALL
Bristol-Myers Squibb
BMY
$136B
$1.65M 1.78%
+26,000
New +$1.67M
EW icon
21
Edwards Lifesciences
EW
$52B
$1.63M 1.76%
35,070
-21,810
-38% -$947K
CME icon
22
CME Group
CME
$103B
$1.49M 1.61%
9,205
-1,025
-10% -$163K
TWTR
23
DELISTED
Twitter, Inc.
TWTR
$1.42M 1.53%
+48,932
New +$1.43M
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.24T
$1.4M 1.51%
26,920
+4,980
+23% +$276K
BIDU icon
25
Baidu
BIDU
$32.9B
$1.33M 1.44%
5,969
-4,084
-41% -$1.01M
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Partner Investment Management held 102 positions worth $92.6M, up 6.6% from $86.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management's Q1 2018 filing shows 26 new, 26 increased, 27 reduced and 15 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,719 shares worth $3.52M. The largest sale was Sienna Biopharmaceuticals, Inc., an estimated $4.96M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 60% a quarter earlier, followed by Technology and Miscellaneous.

  • Partner Investment Management's largest Q1 2018 buy was Bristol-Myers Squibb: 55,719 shares worth $3.52M.
  • Partner Investment Management added most to Elevance Health in Q1 2018, an estimated $1.89M increase.
  • Partner Investment Management's biggest Q1 2018 reduction was Sienna Biopharmaceuticals, Inc., cutting an estimated $4.96M.
  • Partner Investment Management fully exited ServiceNow in Q1 2018, selling an estimated $1.78M.
  • Partner Investment Management's ten largest holdings make up 32% of its $92.6M portfolio in Q1 2018.
  • Partner Investment Management opened 26 new positions and closed 15 in Q1 2018.
  • Partner Investment Management's portfolio value rose 6.6% quarter-over-quarter to $92.6M.

Based on Partner Investment Management's 13F filing for Q1 2018, filed 15 May 2018.